Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)
| CAPS Rating |
|
|---|---|
| Open | $81.39 |
| Previous Close | $80.41 |
| Daily Range | $81.07 - $83.88 |
| 52-Week Range | $42.04 - $83.10 |
| Market Cap | $15.40B |
| P/E Ratio | 111.30 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 2,062,123 |
| Average Daily Volume | 0 |
ALXN
VS S&P 500 (SPY)
How do you think ALXN will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
ALXN Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
ALXN News and Commentary
- Alexion Exits 2011 on a Strong Note - Analyst Blog – NASDAQ
- Alexion Takes Over Enobia Pharma - Analyst Blog – NASDAQ
- Make Money in Growing Health Care Stocks the Easy Way – The Motley Fool
- 3 Stocks Near 52-Week Highs Worth Selling – The Motley Fool
- Tracking 5 Jim Cramer Picks From Jan 5th and 6th – Blogs @ The Motley Fool
- Make Money in Growing Health-Care Stocks the Easy Way – The Motley Fool
- Are These Biotech Drug Launches Back on Track? – The Motley Fool
- Too Early for a New Biotech Orphan? – The Motley Fool
- US Stock Futures: HOT STOCKS TO WATCH – SmartMoney
- US Stock Futures: HOT STOCKS TO WATCH – SmartMoney
- Alexion Cut to Neutral - Analyst Blog – NASDAQ
- TIP SHEET: Fidelity Manager Sees Opportunity In Biotech Funding Crunch – SmartMoney
- TIP SHEET: Fidelity Manager Sees Opportunity In Biotech Funding Crunch – SmartMoney
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape – NASDAQ
- New Danger for Small-Time Investors – SmartMoney
- Alexion Looks Fine With These 2 Metrics – The Motley Fool
- Alexion's Soliris EU Label Expands - Analyst Blog – NASDAQ
- Black Friday Buying and Nasdaq Bargains – NASDAQ
- Five Companies Worth a Second Look in 2012 – NASDAQ
- Momentum Ideas: Top 7 Rallies to Keep on Your Radar – NASDAQ
RSS Headlines
Fool UK
